Hanmi Science Co Ltd
KRX:008930

Watchlist Manager
Hanmi Science Co Ltd Logo
Hanmi Science Co Ltd
KRX:008930
Watchlist
Price: 29 050 KRW -0.34% Market Closed
Market Cap: 2T KRW
Have any thoughts about
Hanmi Science Co Ltd?
Write Note
Hanmi Science Co Ltd
/
Income Statement
/
Gain/Loss on Disposition of Assets

Hanmi Science Co Ltd
Gain/Loss on Disposition of Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hanmi Science Co Ltd
Gain/Loss on Disposition of Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gain/Loss on Disposition of Assets CAGR 3Y CAGR 5Y CAGR 10Y
Hanmi Science Co Ltd
KRX:008930
Gain/Loss on Disposition of Assets
-₩1.8m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Gain/Loss on Disposition of Assets
₩3.6B
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Gain/Loss on Disposition of Assets
-₩18.7m
CAGR 3-Years
-302%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Gain/Loss on Disposition of Assets
₩46.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Gain/Loss on Disposition of Assets
-₩105.6m
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Gain/Loss on Disposition of Assets
₩11.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
No Stocks Found

Hanmi Science Co Ltd
Glance View

Market Cap
2T KRW
Industry
Pharmaceuticals

Hanmi Science Co Ltd, rooted in the vibrant economic landscape of South Korea, charts a compelling narrative of innovation and strategic positioning in the pharmaceutical industry. This company, established in the mid-1960s, has evolved into a pivotal player by capitalizing on its robust research and development initiatives. It operates primarily through its subsidiary, Hanmi Pharmaceutical, leveraging cutting-edge biotechnology to engineer novel drug formulations. Their core business model rests on leveraging proprietary technologies to transition new chemical entities from the lab to the market, focusing on niche therapeutic areas such as oncology, diabetes, and autoimmune diseases. By pursuing an aggressive patent strategy, Hanmi Science not only underscores its commitment to innovation but also fortifies its revenue streams by licensing these patented technologies to global pharmaceutical heavyweights. Revenue generation for Hanmi Science is intrinsically tied to its capacity to scale its biotech advances. The company's income flows primarily from licensing agreements, where its patented drug technologies are adopted by international partners, bringing in a steady stream of licensing fees and milestone payments. Additionally, Hanmi selectively engages in product distribution across multiple international markets, further diversifying its revenue base. This strategic mix of monetary inflow via direct product sales and licensing agreements allows Hanmi Science to reinvest substantial portions back into research and development, fueling a cycle of continuous innovation and market competitiveness. Through this dynamic model, Hanmi Science dexterously navigates the complexities of the pharmaceutical landscape, cementing its status as an innovator and a reliable partner in global health advancements.

Intrinsic Value
26 451.35 KRW
Overvaluation 9%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Hanmi Science Co Ltd's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
-1.8m KRW

Based on the financial report for Sep 30, 2024, Hanmi Science Co Ltd's Gain/Loss on Disposition of Assets amounts to -1.8m KRW.

What is Hanmi Science Co Ltd's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 3Y
69%

Over the last year, the Gain/Loss on Disposition of Assets growth was 81%. The average annual Gain/Loss on Disposition of Assets growth rates for Hanmi Science Co Ltd have been 69% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.